Net profit of Tatva Chintan Pharma Chem rose 720.00% to Rs 9.02 crore in the quarter ended March 2026 as against Rs 1.10 crore during the previous quarter ended March 2025. Sales rose 23.24% to Rs 132.67 crore in the quarter ended March 2026 as against Rs 107.65 crore during the previous quarter ended March 2025.
For the full year,net profit rose 11742.42% to Rs 39.08 crore in the year ended March 2026 as against Rs 0.33 crore during the previous year ended March 2025. Sales rose 35.45% to Rs 496.30 crore in the year ended March 2026 as against Rs 366.42 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 132.67 | 107.65 | 23 | 496.30 | 366.42 | 35 |
| OPM % | 20.00 | 7.35 | - | 18.00 | 7.05 | - |
| PBDT | 24.72 | 8.82 | 180 | 90.01 | 28.11 | 220 |
| PBT | 14.97 | 1.56 | 860 | 53.17 | 0.46 | 11459 |
| NP | 9.02 | 1.10 | 720 | 39.08 | 0.33 | 11742 |
Powered by Capital Market - Live News
